Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Journal of Biomolecular Screening
|
August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening
Laura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
Science Advances
|
June 5, 2020
Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment
Leiming Wang, Chiang-Min Cheng, Jun Qin, et al.
Assay and Drug Development Technologies
|
May 3, 2008
A fluorescence-based thiol quantification assay for ultra-high-throughput screening for inhibitors of coenzyme A production
Christine C Chung, Kenji Ohwaki, Jonathan E Schneeweis, et al.
Journal of Medicinal Chemistry
|
December 13, 2012
Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease
Jon Jacobs, Valerie Grum-Tokars, Ya Zhou, et al.
Molecular Neuropsychiatry
|
March 30, 2018
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders
Timothy P Spicer, Christopher Hubbs, Thomas Vaissiere, et al.
Cancer Research
|
January 7, 2014
Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1
Ying Wang, David M Lonard, Yang Yu, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists
Jeffrey J Hale, Christopher L Lynch, William Neway, et al.
Journal of Biomolecular Screening
|
March 13, 2014
Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening
Timothy Spicer, Virneliz Fernandez-Vega, Peter Chase, et al.
ACS Chemical Biology
|
September 24, 2015
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O Abdul-Hay, Thomas D Bannister, Hui Wang, et al.
Elife
|
July 21, 2016
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
Lars Plate, Christina B Cooley, John J Chen, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Journal of Biomolecular Screening
|
August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening
Laura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
Science Advances
|
June 5, 2020
Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment
Leiming Wang, Chiang-Min Cheng, Jun Qin, et al.
Assay and Drug Development Technologies
|
May 3, 2008
A fluorescence-based thiol quantification assay for ultra-high-throughput screening for inhibitors of coenzyme A production
Christine C Chung, Kenji Ohwaki, Jonathan E Schneeweis, et al.
Journal of Medicinal Chemistry
|
December 13, 2012
Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease
Jon Jacobs, Valerie Grum-Tokars, Ya Zhou, et al.
Molecular Neuropsychiatry
|
March 30, 2018
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders
Timothy P Spicer, Christopher Hubbs, Thomas Vaissiere, et al.
Cancer Research
|
January 7, 2014
Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1
Ying Wang, David M Lonard, Yang Yu, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists
Jeffrey J Hale, Christopher L Lynch, William Neway, et al.
Journal of Biomolecular Screening
|
March 13, 2014
Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening
Timothy Spicer, Virneliz Fernandez-Vega, Peter Chase, et al.
ACS Chemical Biology
|
September 24, 2015
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O Abdul-Hay, Thomas D Bannister, Hui Wang, et al.
Elife
|
July 21, 2016
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
Lars Plate, Christina B Cooley, John J Chen, et al.
Page
of 8